Dabrafenib plus trametinib candidates for standard-of-care in BRAF V600-mutated paediatric low-grade glioma

Presented By

Prof. Eric Bouffet, University of Toronto, Canada

Conference

ASCO 2022

5 August, 2022 15:30

Higher response rates for concurrent triple therapy versus sequential therapy in melanoma

Presented By

Prof. Georgina Long, The University of Sydney, Australia

Trial

Phase 2, NeoTrio

Conference

ASCO 2022

5 August, 2022 13:50

Presented By

Dr Robert van den Heuvel, Medicom

Conference

ASCO 2022

21 June, 2022 09:38

Conference

ESMO 2020

25 November, 2020 14:52

Presented By

Prof. Claus Garbe; Prof. Caroline Robert

Trial

COMBI-d, COMBI-v, COMBI-i, KEYNOTE-001

Conference

WCD 2019

26 August, 2019 20:46